WCM
IDXX icon

Winthrop Capital Management’s Idexx Laboratories IDXX Stock Holding History

Winthrop Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Hold
3
– – ﹤0.01% 280
2025
Q4 		$2K Hold
3
– – ﹤0.01% 288
2025
Q3 		$2K Hold
3
– – ﹤0.01% 262
2025
Q2 		$2K Hold
3
– – ﹤0.01% 266
2025
Q1 		$1K Hold
3
– – ﹤0.01% 283
2024
Q4 		$1K Hold
3
– – ﹤0.01% 295
2024
Q3 		$2K Hold
3
– – ﹤0.01% 133
2024
Q2 		$1K Hold
3
– – ﹤0.01% 145
2024
Q1 		$2K Buy
+3
New +$1.64K ﹤0.01% 127

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Winthrop Capital Management's IDXX Position: Q1 2026 in Review

Winthrop Capital Management held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 3 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Winthrop Capital Management first reported a position in IDXX in Q1 2024 and has held it in 9 quarters since. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Winthrop Capital Management held 3 shares of Idexx Laboratories worth $2K as of Q1 2026.
  • Winthrop Capital Management left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up ﹤0.01% of Winthrop Capital Management's portfolio in Q1 2026, its #280 holding.
  • Winthrop Capital Management first reported a position in Idexx Laboratories in Q1 2024 and has held it in 9 quarters since.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Winthrop Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.